• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.28% Nasdaq Up0.17%

    Haemonetics Corporation (HAE)

    32.61 Up 0.51(1.59%) Oct 12, 4:01PM EDT
    ProfileGet Profile for:
    Haemonetics Corporation
    400 Wood Road
    Braintree, MA 02184
    United States - Map
    Phone: 781-848-7100
    Website: http://www.haemonetics.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:3,383

    Business Summary 

    Haemonetics Corporation designs, manufactures, and markets blood management solutions. The company operates through North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific, and Japan segments. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components in the lab; and manual collection, filtration, and processing products. The company also offers hospital products comprising TEG thrombelastograph hemostasis analyzer systems that measure a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver systems for cardiovascular surgeries; and OrthoPAT surgical blood salvage systems for orthopedic procedures. In addition, it provides IMPACT Online blood management portal to monitor the results of its new blood management practices; SafeTrace Tx that manages blood product inventory and transfusions, and performs patient cross-matching; BloodTrack to manage tracking and control of blood products from the hospital blood center; and SafeTrace and El Dorado Donor donation and blood unit management systems, as well as Hemasphere, Donor Doc, and e-Donor software solutions. The company markets and sells its products to bio-pharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Haemonetics Corporation

    Corporate Governance 
    Haemonetics Corporation’s ISS Governance QuickScore as of Oct 1, 2015 is 5. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 7; Compensation: 5.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Ronald G. Gelbman , 67
    Interim Chief Exec. Officer, Lead Director, Chairman of Governance & Compliance Committee and Member of Audit Committee
    Mr. Christopher J. Lindop , 57
    Chief Financial Officer and Exec. VP of Bus. Devel.
    Mr. Kent J. Davies , 52
    Chief Operating Officer
    Mr. Brian R. Burns , 51
    Exec. VP of Global Quality and Regulatory Affairs
    Ms. Susan M. Hanlon , 47
    Chief Accounting Officer and VP of Fin.
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders